Computational drug design and chemo-informatics: a hands-on course at the University of Antwerp

The University of Antwerp is the third-largest university in the Dutch-speaking region of Belgium, with over 20,000 students annually. Within the Biochemistry and Biotechnology curriculum, students have the option to take a three-ECTS course on computational drug design and chemo-informatics. The course is organized in a modular fashion and covers both theoretical and practical sessions.

During the theoretical sessions, students learn about chemo-informatics and virtual screening, which includes concepts such as chemical fingerprints, molecular similarity, clustering, machine learning models, and virtual screening performance metrics. The course also covers molecular docking and pharmacophore searching. The concepts covered in the theoretical sessions are then put into practice in a series of hands-on sessions.

For the chemo-informatics tasks, the students use Google Colab with RDKit as a chemo-informatics toolkit, while for the pharmacophore and docking-related aspects, they use Maestro, Phase, and Glide. These tools are made available through the “Teaching with Schrödinger” web-based virtual workstations, which allows students to access them from anywhere at any time. Finally, using an internally-developed virtual reality system, the students can graphically study the non-bonded interactions between ligand and protein.

At the start of the course, a drug design project is defined based on ongoing research programs in the Faculty. The goal of the project is to identify a limited number of commercially-available compounds (5-10) that are subsequently purchased and biochemically characterized for their inhibitory properties. The students complete the program with a written report, which serves as the basis for the oral examination at the end.

Our Speaker

Prof. Hans De Winter

Professor, University of Antwerp

Hans De Winter was appointed in 2013 as a professor of Computational Drug Design at the University of Antwerp (Belgium) after a long career in industry, first as a senior scientist at Johnson & Johnson in Beerse, Belgium, and subsequently as a co-founder and CSO of Silicos NV. He holds a PhD from the University of Leuven (Belgium) and completed post-doctoral stays at the Victorian College of Pharmacy (Australia) and the Rega Institute in Leuven (Belgium) before starting his career as a scientist in the pharmaceutical industry. Despite his elaborated industrial background during a period of more than 20 years, he has over 60 scientific publications and is listed as inventor on eight granted patents. Hans’ research interests are mainly situated in the field of computational medicinal chemistry and cheminformatics.